Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-action Pt(IV) anticancer agents; do we understand how they work?
Dan Gibson
Journal of Inorganic Biochemistry (2018) Vol. 191, pp. 77-84
Closed Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Metallodrugs are unique: opportunities and challenges of discovery and development
Elizabeth J. Anthony, Elizabeth M. Bolitho, Hannah E. Bridgewater, et al.
Chemical Science (2020) Vol. 11, Iss. 48, pp. 12888-12917
Open Access | Times Cited: 526
Metallodrugs in cancer nanomedicine
Quim Peña, Alec Wang, Orysia Zaremba, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 7, pp. 2544-2582
Closed Access | Times Cited: 144
Metal complexes for therapeutic applications
Johannes Karges, Ryjul W. Stokes, Seth M. Cohen
Trends in Chemistry (2021) Vol. 3, Iss. 7, pp. 523-534
Open Access | Times Cited: 127
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 213991-213991
Closed Access | Times Cited: 123
What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives
Kun Peng, Bing‐Bing Liang, Wenting Liu, et al.
Coordination Chemistry Reviews (2021) Vol. 449, pp. 214210-214210
Closed Access | Times Cited: 120
Diazido platinum(iv) complexes for photoactivated anticancer chemotherapy
Huayun Shi, Cinzia Imberti, Peter J. Sadler
Inorganic Chemistry Frontiers (2019) Vol. 6, Iss. 7, pp. 1623-1638
Open Access | Times Cited: 102
Non-platinum complexes containing releasable biologically active ligands
Pavel Štarha, Zdeněk Trávnı́ček
Coordination Chemistry Reviews (2019) Vol. 395, pp. 130-145
Closed Access | Times Cited: 92
Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
Dan Gibson
Journal of Inorganic Biochemistry (2021) Vol. 217, pp. 111353-111353
Closed Access | Times Cited: 90
A view on multi-action Pt(IV) antitumor prodrugs
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, et al.
Inorganica Chimica Acta (2019) Vol. 492, pp. 32-47
Closed Access | Times Cited: 77
Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100778-100778
Open Access | Times Cited: 77
Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum(iv) prodrugs
Shuren Zhang, Xuanmeng Zhong, Hao Yuan, et al.
Chemical Science (2020) Vol. 11, Iss. 15, pp. 3829-3835
Open Access | Times Cited: 72
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 55
Oxaliplatin and its derivatives – An overview
Paul O'Dowd, Darragh F. Sutcliffe, Darren M. Griffith
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215439-215439
Open Access | Times Cited: 33
Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands
Zhiqin Deng, Guangyu Zhu
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102303-102303
Closed Access | Times Cited: 31
Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance
Mona Shahlaei, Shaahin Mohammadzadeh Asl, Atefe Derakhshani, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137366-137366
Closed Access | Times Cited: 25
A ratiometric fluorescent probe for real-time monitoring of intracellular glutathione fluctuations in response to cisplatin
Hanzhuang Liu, Wenting Song, Shuren Zhang, et al.
Chemical Science (2020) Vol. 11, Iss. 32, pp. 8495-8501
Open Access | Times Cited: 60
Expanding the Arsenal of PtIV Anticancer Agents: Multi‐action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group
Thirumal Yempala, Tomer Babu, Subhendu Karmakar, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 50, pp. 18218-18223
Closed Access | Times Cited: 58
A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt IV Complexes under Physiological Conditions
Alexander Kastner, Isabella Poetsch, Josef Mayr, et al.
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 22, pp. 7464-7469
Open Access | Times Cited: 56
Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo
Yan Chen, Qingpeng Wang, Zuojie Li, et al.
Dalton Transactions (2020) Vol. 49, Iss. 16, pp. 5192-5204
Closed Access | Times Cited: 52
Structure–Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands
Philipp Fronik, Isabella Poetsch, Alexander Kastner, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 16, pp. 12132-12151
Open Access | Times Cited: 46
Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, et al.
Dalton Transactions (2021) Vol. 51, Iss. 6, pp. 2121-2134
Closed Access | Times Cited: 46
Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
Claudia Schmidt, Tomer Babu, Hana Kostrhunová, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11364-11378
Closed Access | Times Cited: 43
Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy
Yu Lu, Di Zhu, Quynh Chi Le, et al.
Nanoscale (2022) Vol. 14, Iss. 44, pp. 16339-16375
Open Access | Times Cited: 33
Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands
Pavel Štarha, Radka Křikavová
Coordination Chemistry Reviews (2023) Vol. 501, pp. 215578-215578
Closed Access | Times Cited: 22
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
Alexander Kastner, Theresa Mendrina, Florian Bachmann, et al.
Inorganic Chemistry Frontiers (2023) Vol. 10, Iss. 14, pp. 4126-4138
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top